Back to FDA Applications sponsored by BAYER PHARMS

FDA Drug Application 020740 by BAYER PHARMS

Application Number020740
Application Type New Drug Application
Sponsor ApplicantBAYER PHARMS
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New molecular entity (NME)
Therapeutic Potential Standard
Orphan Code 

Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP06/26/1997N24879000 3/2/2010
AP05/24/1999SE23846002 5/24/1999
AP05/24/1999SE23847002 11/29/2001
AP01/4/1999SLR3848003 11/29/2001
AP03/30/2001SLR3849006 12/3/2001
AP03/30/2001SLR1392006 3/30/2001
AP03/30/2001SLR1393006 3/30/2001
AP012/10/1999SCS17922007 9/24/2007
AP07/21/2000SE24534008 7/21/2000
AP07/21/2000SE23850008,13LTR.PDF 7/23/2000
AP07/21/2000SE23851008 11/29/2001
AP012/22/1999SCS17921010 9/24/2007
AP07/3/2000SCM17920012 9/24/2007
AP07/21/2000SE14535013 7/21/2000
AP07/21/2000SE13852013,13LTR.PDF 7/23/2000
AP07/21/2000SE13853013 11/29/2001
AP011/6/2000SLR3854014 12/3/2001
AP01/23/2001SCE19160016 2/19/2008
AP05/10/2001SCS3855018 12/3/2001
AP05/10/2001SCS5415018 4/22/2003
AP05/21/2001SLR5430019 4/23/2002
AP05/21/2001SLR4434019 12/3/2001

Back to FDA Applications sponsored by BAYER PHARMS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer

Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.